Stability of propafenone hydrochloride in i.v. solutions

被引:3
|
作者
Dupuis, LL
Wong, B
Trope, A
机构
[1] UNIV TORONTO,FAC PHARM,TORONTO,ON,CANADA
[2] MERCK SHARP & DOHME LTD,HONG KONG,HONG KONG
[3] HOSP SICK CHILDREN,DEPT PHARM,PEDIAT CRIT CARE UNIT,TORONTO,ON M5G 1X8,CANADA
关键词
cardiac drugs; concentration; containers; dextrose; diluents; freezing; incompatibilities; injections; plastics; polymers; polypropylene; polystyrene; polyvinyl chloride; precipitation; propafenone hydrochloride; sodium chloride; stability; storage; syringes; temperature;
D O I
10.1093/ajhp/54.11.1293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of propafenone hydrochloride in i.v. solutions was studied. Solutions of propafenone hydrochloride 2, 1,and 0.5 mg/mL in 5% dextrose injection and in 5% dextrose and 0.2% sodium chloride injection were prepared. Portions of each type of solution were transferred to 10-mL polypropylene syringes and to 150-mL polyvinyl chloride (PVC) bags. Syringes and bags were stored at 20.5-22.5 degrees C under fluorescent light. Two 0.5-mL samples were drawn from each container at 0, 6, 12, 24, 36, and 48 hours and frozen in polystyrene tubes at -20 degrees C until assayed. Propafenone concentrations were determined by high-performance liquid chromatography. All samples of propafenone hydrochloride 2 mg/mL in 5% dextrose and 0.2% sodium chloride injection taken from PVC bags Precipitated when thawed. For the remaining solutions, the mean decrease from the initial concentration was <10% regardless of diluent, container type, and initial concentration. Propafenone hydrochloride 1 and 0.5 mg/mL in 5% dextrose injection or in 5% dextrose and 0.2% sodium chloride injection was stable for 48 hours at 20.5-22.5 degrees C when stored in polypropylene syringes or PVC bags. Propafenone hydrochloride 2 mg/mL in 5% dextrose injection was stable for 48 hours when stored in syringes or bags, but in 5% dextrose and 0.2% sodium chloride injection was stable in syringes only.
引用
收藏
页码:1293 / 1295
页数:3
相关论文
共 50 条
  • [21] I.V. Koshel - In memoriam
    不详
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2003, 48 (03): : COVER3 - COVER3
  • [22] Extravasation of i.v. promethazine
    Malesker, MA
    Malone, PM
    Cingle, CM
    Cochran, RM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (17) : 1742 - 1743
  • [23] PROKHOROV,I.V. HYPOTHESIS
    MARTIKAINEN, AI
    DOKLADY AKADEMII NAUK SSSR, 1984, 276 (05): : 1064 - 1066
  • [24] TANANAEV,I.V. - MEMORIES
    DZHURINSKII, BF
    JOURNAL OF ANALYTICAL CHEMISTRY, 1993, 48 (09) : 1112 - 1113
  • [25] Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS
    Andersson, Borje S.
    de Lima, Marcos
    Thall, Peter F.
    Wang, Xuemei
    Couriel, Daniel
    Korbling, Martin
    Roberson, Soonja
    Giralt, Sergio
    Pierre, Betty
    Russell, James A.
    Shpall, Elizabeth J.
    Jones, Roy B.
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 672 - 684
  • [26] Possible adverse reactions to preservatives in high-dose pyridoxine hydrochloride i.v. injection
    Burda, AM
    Sigg, T
    Wahl, M
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (19) : 1886 - 1887
  • [27] STALIN,I.V. I PEREDOVAYA NAUKA
    不详
    BIOKHIMIYA, 1950, 15 (01): : 1 - 7
  • [28] Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration
    Glover, Zephania W. Kwong
    Gennaro, Lynn
    Yadav, Sandeep
    Demeule, Barthelemy
    Wong, Pin Yee
    Sreedhara, Alavattam
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (03) : 794 - 812
  • [29] Cost-effectiveness of i.v. ibandronic acid versus i.v. zoledronic acid and i.v. pamidronate for metastatic bone disease from breast cancer
    Hutton, John
    De Cock, Erwin
    Barrett-Lee, Peter
    Canney, Peter
    Body, Jean-Jacques
    Neary, Maureen
    Lewis, Gavin
    ANNALS OF ONCOLOGY, 2004, 15 : 50 - 51
  • [30] Care needed with i.v. acetaminophen
    Palmer, Katherine A.
    Shane, Rita
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (19) : 1775 - 1776